Lawsuit Cerave Sunscreen

Cerave Sunscreen Lawsuit

Valeant Pharmaceuticals is at the center, accused of deceptive marketing and fraudulent practices with their CeraVe sunscreen. The class action lawsuit alleges that the company mislabeled ingredients, breaching consumer protection laws. The plaintiffs claim that Valeant’s marketing claims didn’t match the actual ingredients of the sunscreen, leading to consumer deception.

As a result, they’re seeking damages for their monetary losses due to these alleged fraudulent practices. The lawsuit isn’t just about financial recompense, though.

Here’s a brief rundown:

  1. The Parties: Valeant Pharmaceuticals, the manufacturer of CeraVe sunscreen, is the defendant. Consumers who feel taken advantage of by the company’s dishonest marketing strategies are the plaintiffs.
  2. The Cause: The lawsuit alleges that Valeant violated consumer protection laws by misrepresenting the ingredients in their sunscreen.
  3. Relief: The plaintiffs seek damages for the money they lost due to Valeant’s alleged fraudulent practices.

The case is currently ongoing.

Cerave Sunscreen Lawsuit Explanation

The makers of CeraVe, Valeant Pharmaceuticals, are accused of deceptive marketing in a class action lawsuit. The action was taken in the U.S. District Court for the Central District of California. The crux of the lawsuit revolves around the inclusion of potentially harmful substances, namely phenoxyethanol and ethylhexylglycerin, in the sunscreen’s formulation.

You, as a consumer, might be wondering how this affects you. Well, the lawsuit seeks damages on behalf of all consumers who were misled into purchasing the product under false pretenses. If you’ve purchased CeraVe Baby Sunscreen, you might’ve been under the impression that you were buying a safe, gentle product for your child’s skin.

However, the presence of phenoxyethanol and ethylhexylglycerin, ingredients that some believe could pose potential health risks, could mean you didn’t get what you paid for.

Parties involved

In this lawsuit, the plaintiffs, Mary Yoon and Christina Labajo, claim they were deceived into buying CeraVe Baby Sunscreen by Valeant Pharmaceuticals. They claim that the business misled them into buying a product with harmful ingredients. This misrepresentation, they assert, resulted in them seeking damages for the harm they believe they’ve suffered.

The reputable law firm Bursor & Fisher PA is handling this case, which is a class action lawsuit. They’re representing the interests of Yoon and Labajo, who are the primary plaintiffs in this lawsuit. Their goal is to ensure that justice is served and that their clients receive the compensation they deserve for the alleged damages.

The lawsuit has been filed in the U.S. District Court for the Central District of California. This is a significant detail, as it determines the jurisdiction and the laws that will apply to the case. It’s also crucial to keep in mind that, even though Yoon and Labajo are the named plaintiffs, the class action lawsuit could potentially include others who may have fallen victim to CeraVe Baby Sunscreen’s deception.

The cause of action

It’s crucial to understand that the lawsuit primarily revolves around deceptive marketing claims by Valeant Pharmaceuticals about CeraVe Baby Sunscreen’s ingredients. The class action lawsuits allege that you, as a consumer, were misled into buying a product containing potentially harmful ingredients. These include substances like phenoxyethanol, ethylhexylglycerin, and C12-15 alkylbenzoate.

The lawsuit argues that the company violated various consumer protection laws by not accurately representing the product’s composition in its marketing. This discrepancy between the product’s advertised and actual ingredients is at the heart of the legal issue. Essentially, what was promised on the label didn’t match what was inside the tube, and you were left with a product that could potentially harm your child.

Relief being sought

They’re looking for damages to compensate for the monetary losses they’ve suffered due to the alleged fraudulent practices of the defendants.

The plaintiffs argue that the company has benefited unfairly from misleading packaging labels, which they believe is unjust enrichment. Part of their argument is that CeraVe provided deceptive information about the sunscreen’s effectiveness, leading consumers to purchase a product that didn’t live up to its promises.

This isn’t just about a single product, though. The plaintiffs have invoked various state consumer protection laws to tackle what they perceive as a wider issue. They see the company’s actions as part of a pattern of unlawful practices, unfair practices, and deceitful practices that go beyond this one product.

In essence, the plaintiffs are seeking a judgment that won’t only compensate them for their losses but also hold CeraVe accountable for what they believe are unethical business practices. They want to ensure that others won’t fall victim to the same alleged misleading tactics.

Key events and timeline

A new class action lawsuit was filed against Valeant Pharmaceuticals International, claiming that it falsely marketed CeraVe Baby Sunscreen. The claims stem from allegations that the company provided deceptive information about the sunscreen’s ingredients, suggesting they were naturally sourced.

However, it appears that the sunscreen contains synthetic ingredients that could potentially harm babies’ sensitive skin. These allegations have raised serious concerns among consumers and led to accusations of fraudulent practices. The plaintiffs in this case are now seeking damages for their monetary losses.

This lawsuit falls under various consumer protection laws. These laws aim to protect consumers from unfair, deceptive, or fraudulent business practices, and in this case, it’s clear that Valeant Pharmaceuticals stands accused of such practices.

Key arguments

Moving on to the key arguments in this lawsuit, you’ll find that the plaintiff’s main contention revolves around the alleged deceptive marketing practices by Valeant Pharmaceuticals. This CeraVe sunscreen lawsuit is grounded in various consumer protection laws. Plaintiffs claim that Valeant violated these laws by falsely advertising its product, leading to monetary losses and unfair practices.

A significant part of the lawsuit focuses on ingredient scrutiny. Ingredients like phenoxyethanol, ethylhexylglycerin, and C12-15 alkyl benzoate present in CeraVe Baby Sunscreen are under the microscope. These potentially harmful synthetic components, the plaintiffs argue, aren’t indicated on the packaging labels, misleading consumers about the product’s safety.

Furthermore, the plaintiffs assert that the misleading packaging labels constitute breaches of express warranty. They argue that Valeant unjustly enriched itself by marketing a product that didn’t live up to its claims. In simple terms, the company is accused of selling a product that wasn’t as advertised, contravening consumer trust and protection rights.

Current status

Currently, the CeraVe sunscreen lawsuit is in progress, with plaintiffs Mary Yoon and Christina Labajo seeking damages for being misled about the product’s ingredients. Their claim centers around the alleged presence of synthetic and potentially harmful substances in the CeraVe Baby Sunscreen, which they say weren’t disclosed to consumers.

The case was brought forth in December without a clear resolution in sight. The focus isn’t just on the damages but also on holding the company accountable for misleading its customers. The goal of the lawsuit is to ensure consumers have accurate information about the products they use, particularly when it comes to potentially harmful ingredients.

Lawsuit Cerave Sunscreen


You might ask, How could this affect you or the sunscreen industry in general? Here are three possible implications:

  1. Increased Scrutiny of Ingredients: The lawsuit has put ingredients like phenoxyethanol and ethylhexylglycerin under scrutiny. This could lead to more transparency in the industry about what’s in our sunscreen.
  2. Clarity on Natural vs. Synthetic: The lawsuit highlights the discrepancy between marketing claims and actual ingredients. This could result in stricter regulations about labeling natural vs. synthetic ingredients.
  3. Potential for More Lawsuits: If Bursor & Fisher PA, the legal team representing the plaintiffs, wins the class action, it could encourage more consumers to sue companies for deceptive marketing practices.


You, as a consumer, may be worried about the undisclosed oils in the sunscreen, which include synthetic substances like phenoxyethanol and ethylhexylglycerin. These potentially harmful ingredients have raised eyebrows and caused unease among consumers who’ve been misled into buying the product.

On the industry side, companies are on high alert, scrutinizing their own practices to avoid similar accusations. The lawsuit, which Bursor & Fisher PA is leading, has emphasized the significance of ingredient disclosure transparency and the potential consequences of failing to do so.

This lawsuit hasn’t only exposed Valeant Pharmaceuticals’ alleged deceptive marketing but also highlighted the need for stringent checks on products, especially those meant for babies. The reactions to this lawsuit serve as a reminder for all companies that customer trust can easily be lost through undisclosed ingredients and potentially harmful synthetic oils.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *